| Tissue Specificity | Liver and intestine. |
| Post Translational Modifications | Proapolipoprotein C-II is synthesized as a sialic acid containing glycoprotein which is subsequently desialylated prior to its proteolytic processing. Proapolipoprotein C-II, the major form found in plasma undergoes proteolytic cleavage of its N-terminal hexapeptide to generate apolipoprotein C-II, which occurs as the minor form in plasma. |
| Function | Component of chylomicrons, very low-density lipoproteins (VLDL), low-density lipoproteins (LDL), and high-density lipoproteins (HDL) in plasma. Plays an important role in lipoprotein metabolism as an activator of lipoprotein lipase. Both proapolipoprotein C-II and apolipoprotein C-II can activate lipoprotein lipase. In normolipidemic individuals, it is mainly distributed in the HDL, whereas in hypertriglyceridemic individuals, predominantly found in the VLDL and LDL. |
| Protein Name | Apolipoprotein C-IiApo-CiiApoc-IiApolipoprotein C2 Cleaved Into - Proapolipoprotein C-IiProapoc-Ii |
| Database Links | Reactome: R-HSA-8963888Reactome: R-HSA-8963889Reactome: R-HSA-8963901Reactome: R-HSA-8964058Reactome: R-HSA-9029569Reactome: R-HSA-975634 |
| Cellular Localisation | Secreted |
| Alternative Antibody Names | Anti-Apolipoprotein C-Ii antibodyAnti-Apo-Cii antibodyAnti-Apoc-Ii antibodyAnti-Apolipoprotein C2 Cleaved Into - Proapolipoprotein C-Ii antibodyAnti-Proapoc-Ii antibodyAnti-APOC2 antibodyAnti-APC2 antibody |
Information sourced from Uniprot.org
